Skip to main content
Clinical Trials/NCT01415219
NCT01415219
Completed
Phase 2

Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis

University Hospital, Lille5 sites in 1 country80 target enrollmentMarch 1, 2008

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Dermatomyositis
Sponsor
University Hospital, Lille
Enrollment
80
Locations
5
Primary Endpoint
HAQ score
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

The purpose of this study is to evaluate the efficacy of an active rehabilitation program on disability and quality of life of patients affected by dermatomyositis and polymyositis.

Detailed Description

Dermatomyositis (DM) and polymyositis (PM) are inflammatory disabling neuromuscular disorders. Despite partial benefit of pharmacological treatments, muscle strength, functional status and quality of life remain impaired. Although the use muscle exercises in (DM) and (PM) have been reported, its efficacy on disability and quality of life has not been proved. Te aim of the study is to evaluate the benefit at mid term (12 months) of an active rehabilitation program administrated to patients affected by PM and DM. Method: a 3 year prospective, multicentric, randomized controlled trial A program of 12 individual exercise sessions (3 per week during 4 weeks) is compared to conventional care. Patients are followed 12 month after the inclusion.

Registry
clinicaltrials.gov
Start Date
March 1, 2008
End Date
December 1, 2013
Last Updated
4 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Hospital, Lille
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • diagnosis of Dermatomyositis ore polymyositis according to the International Myositis Assessment and Clinical Studies Group
  • functional impairment (an HAQ score greater than 0.5)
  • stability of muscle impairment
  • medical insurance

Exclusion Criteria

  • no recent inflammatory activity
  • other chronic disease
  • cognitive impairment
  • patients who participated to a rehabilitation program before inclusion

Outcomes

Primary Outcomes

HAQ score

Time Frame: 6 month and 1 year after rehabilitation

Secondary Outcomes

  • muscle strength (MRC manual muscle testing)(at 6 month and one year after rehabilitation)
  • Quality of life (SF36 score)(6 month and 1 year after rehabilitation)
  • MFM(motor function measure)(6 month and one year after rehabilitation)

Study Sites (5)

Loading locations...

Similar Trials